WallStreetZenWallStreetZen

NASDAQ: GHRS
Gh Research PLC Stock Forecast, Predictions & Price Target

Analyst price target for GHRS

Based on 2 analysts offering 12 month price targets for Gh Research PLC.
Min Forecast
$39.00+251.99%
Avg Forecast
$39.50+256.5%
Max Forecast
$40.00+261.01%

Should I buy or sell GHRS stock?

Based on 2 analysts offering ratings for Gh Research PLC.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GHRS stock forecasts and price targets.

GHRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-04
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is GHRS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is GHRS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GHRS revenue forecast

What is GHRS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$101.3M
Avg 2 year Forecast
$286.7M
Avg 3 year Forecast
$520.1M

GHRS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GHRS$11.08$39.50+256.50%Buy
NVAX$4.15$19.00+357.83%Buy
NUVB$2.66$6.60+148.12%Strong Buy
LYEL$2.30$6.00+160.87%Buy
OLMA$10.15$22.50+121.67%Strong Buy

Gh Research Stock Forecast FAQ

Is Gh Research Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GHRS) stock is to Buy GHRS stock.

Out of 2 analysts, 0 (0%) are recommending GHRS as a Strong Buy, 2 (100%) are recommending GHRS as a Buy, 0 (0%) are recommending GHRS as a Hold, 0 (0%) are recommending GHRS as a Sell, and 0 (0%) are recommending GHRS as a Strong Sell.

If you're new to stock investing, here's how to buy Gh Research stock.

What is GHRS's revenue growth forecast for 2027-2029?

(NASDAQ: GHRS) Gh Research's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Gh Research's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GHRS's revenue for 2027 to be $5,270,451,089, with the lowest GHRS revenue forecast at $5,270,451,089, and the highest GHRS revenue forecast at $5,270,451,089. On average, 1 Wall Street analysts forecast GHRS's revenue for 2028 to be $14,916,469,172, with the lowest GHRS revenue forecast at $14,916,469,172, and the highest GHRS revenue forecast at $14,916,469,172.

In 2029, GHRS is forecast to generate $27,059,838,215 in revenue, with the lowest revenue forecast at $27,059,838,215 and the highest revenue forecast at $27,059,838,215.

What is GHRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GHRS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GHRS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GHRS price target, the average GHRS price target is $39.50, with the highest GHRS stock price forecast at $40.00 and the lowest GHRS stock price forecast at $39.00.

On average, Wall Street analysts predict that Gh Research's share price could reach $39.50 by Mar 4, 2025. The average Gh Research stock price prediction forecasts a potential upside of 256.5% from the current GHRS share price of $11.08.

What is GHRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GHRS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.